SAA is an acute phase apolipoprotein that modulates inflammation via NF-κB signaling.20It is highly expressed in sarcoidosis granulomas,21elevated in the serum of sarcoidosis patients,22, 23correlates with treatment need, and may serve as a biomarker for disease. Here, NFKB1 is linked to sarcoidosis.